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Background: Since the advent of health user fees in low- and middle-income countries in the 1980s, the discourse
of global health actors (GHAs) has changed to the disadvantage of this type of healthcare financing mechanism.
The aim of the study was to identify and analyze the stance of GHAs in the debate on user fees.
Methods: We conducted documentary research using public documents published by and officially attributed to
GHAs from 2005 to 2011. We categorized GHAs into four groups: intergovernmental organizations, international
non-governmental organizations, government agencies, and working groups and networks. We then classified the
GHAs according to their stance relative to the abolition of user fees, and conducted a thematic analysis of their
discourse to understand the arguments used by each GHA to justify its stance.
Results: We identified 56 GHAs, for which we analyzed 140 documents. Among them, 55% were in favor of the
abolition of user fees or in favor of free care at the point of delivery. None of the GHAs stated that they were in
favor of user fees; however, 30% did not take a stand. Only the World Bank declares that it is both in favor of user
fees and in favor of free care at point of service. GHAs generally circumscribe their stance to specific populations
(pregnant women, children under 5 years, etc.) or to specific health services (primary, basic, essential). Three types
of arguments are used by GHAs to justify their stance: economic, moral and ethical, and pragmatic.
Conclusions: The principle of “user pays” seems to have fizzled. Production and dissemination of evidence, as well
as certain advocacy networks, may have contributed to this change in discourse. However, GHAs should go a step
further and translate their words into action, so that free healthcare at the point of delivery becomes a reality in
low- and middle-income countries. They should provide technical and financial support to those countries that
have chosen to implement user fee exemption policies, sometimes influenced by a GHA.
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Contexte: Depuis l′avènement des paiements directs des soins dans les années 1980 dans les pays à faible et
moyen revenu, le discours des acteurs de la santé mondiale a évolué en défaveur de ce mode de financement de
la santé. L’objectif de l’étude est de déterminer et d’analyser la position des acteurs de la santé mondiale dans le
débat sur les paiements directs.
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Méthodes: Nous avons mené une recherche documentaire à partir de l’analyse des documents publiés et
officiellement attribués aux acteurs de la santé mondiale entre 2005 et 2011. Nous avons catégorisé les acteurs en
quatre groupes : les organisations intergouvernementales, les organisations internationales non gouvernementales,
les agences gouvernementales de coopération, et les réseaux et groupes de travail transnationaux. Nous avons
ensuite classé chaque acteur selon sa position par rapport à l’abolition des paiements directs. Nous avons enfin
mené une analyse thématique des discours pour comprendre les arguments utilisés par chaque acteur pour
défendre sa position.
Résultats: Nous avons répertorié 56 acteurs de la santé mondiale pour lesquels nous avons retenu 140 documents.
Parmi eux, 55% sont en faveur de l’abolition des paiements directs des soins ou de la gratuité des soins au point de
service. Si aucun acteur ne se prononce plus en faveur des paiements directs, 30% ne prennent pas position. Seule
la Banque Mondiale s'exprime à la fois en faveur des paiements directs et en faveur de la gratuité des soins au
point de service. Les acteurs circonscrivent généralement leur position positive à certaines populations (femmes
enceintes, enfants de moins de 5 ans, etc.) ou à certains soins (soins primaires, de base, essentiels). Trois types
d’arguments sont utilisés par les acteurs pour défendre leur position : économique, moral/éthique et pragmatique.
Conclusion: Le principe de l’utilisateur-payeur semble avoir fait long feu. Les données scientifiques et certains
réseaux d’acteurs ont sans doute contribué à ce changement de discours. Pour autant, les acteurs de la santé
mondiale qui ont maintenant trouvé un consensus ne doivent plus se contenter de prendre position. Ils doivent
transformer leurs paroles en actes et soutenir tant techniquement que financièrement les pays qui ont choisi de
mettre en place des mesures d’exemption, parfois sous leur influence.Background
Universal health coverage is the new objective of the
decade [1] and several low-and middle-income coun-
tries (LMICs), such as India and Ghana, are now test-
ing the principle of sharing the financial risks linked
with access to healthcare. However, such policies are
few in number, especially in Africa [2], and user fees
remain a widespread health financing mechanism [3,4].
The issue of health user fees has been fiercely de-
bated [5] since the publication of the De Ferranti report
[6], and the Agenda for Reform by the World Bank [7],
and the implementation of the Bamako Initiative in the
late 1980s. The financial participation of users of health
services, by means of user fees, was regarded as a way
to improve community participation and access to pri-
mary health care [8], where health systems were weak
and underfunded. Many African countries (e.g. Burkina
Faso, Niger, Senegal, South Africa, Uganda, etc.) and some
countries in Asia (e.g. Burma, Vietnam, Cambodia) and in
Latin America (e.g. Peru, Honduras) reformed their health
system based on this principle [9].
Even in the early years of implementing the Bamako
Initiative in Africa and Asia, voices were raised to de-
nounce the potential risks of such an approach for the
most disadvantaged populations. As a case in point,
the Canadian Public Health Association declared in
1990: “The financial requirements of attaining and sus-
taining PHC [primary health care] must not be met by
imposing an increased financial burden on the poorest
and most vulnerable in society […]” [10]. Studies in
LMICs [11,12] have regularly shown that user feesdeterred the use of health services and threatened
equity [13,14]. However, the evidence is mixed [11,15],
showing, for example, that quality of care improved in
some settings.
Currently there seems to be few strong supporters of
user fees. Indeed, in a context where the objectives of
the Millennium Development Goals are still far from
being achieved, particularly in African countries [16],
health user fees are major barriers to access to care for
vulnerable populations [17]. More than fifteen years
have passed since South Africa has decided to make
health care free for a certain part of its population in
1994. This country paved the way for its neighbors.
Today, despite the multiple setbacks faced by user fee
exemption policies, specifically with regards to imple-
mentation [18], around twenty LMICs, supported by
several international donors, have followed the ex-
ample of South Africa [19].
Some feel that there is now a consensus on the need
to abolish user fees [20,21]: “A consensus is emerging
that user fees are not an appropriate financing mech-
anism for health services in developing countries” [20].
The Lancet editorial of September 2012 with its cat-
egorical statement that direct payments “should be
scrapped” [22] seems to confirm this growing opinion
on the global health scene.
In this study, we sought to determine to what extent a
consensus exists among the various global health actors
(GHAs) on the issue of user fees in LMICs. The object-
ive is therefore to identify and analyze the public pos-
ition statements of GHAs in the debate.
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Research design
As the example of the Bamako Initiative shows, more and
more health reforms and public health policies are initiated
at the supranational level. The “global agora” [23] is now
the place where public policy processes, notably agenda set-
ting, are taking place. Multiple actors, and not only states,
are involved in priority setting in LMICs [24]. Moreover,
the debate on user fees far exceeds the frontiers of the
countries in which they are implemented. We thus decided
to focus on the supranational debate involving GHAs, ra-
ther than local or state actors.
In the frame of a study on a supranational debate,
collecting primary data from stakeholders is hardly feasible.
It is therefore possible to base the study on secondary data,
as explained by Varvasovsky and Brugha [25] : “A supra-na-
tional analysis, involving international actors, is likely to
rely more on a review of policy documents, reports and
existing data” (p.340). We therefore conducted documen-
tary research, facilitated by the abundance of documents
published by GHAs and their accessibility. This type of
study also has the advantage of limiting the influence of the
researcher on the study material [26].
Identification of stakeholders
According to Varvasovsky and Brugha [25], stakeholders
are “actors who have an interest in the issue under consid-
eration, who are affected by the issue, or who – because of
their position – have or could have an active or passive in-
fluence on the decision-making process”.
We initially classified the different types of GHAs
according to the categorization proposed by Evans and
colleagues [27]. They distinguish between: 1) intergovern-
mental organizations (IGOs), composed mainly of member
states and established by treaty, giving them a legal inter-
national status, and 2) international non-governmental
organizations (INGOs), which are voluntary associations
composed of individuals or organizations for international
action. In order to take into consideration the new GHAs
[28], we also included: 3) government agencies (GAs), na-
tional development aid agencies that act in the frame of
bilateral agreements, mostly involving high-income coun-
tries; and 4) working groups and transnational networks
(NW/WGs). Indeed, the globalization of trade is accom-
panied by the emergence of a new category of actors
whose voice on the global health scene is gradually
growing. Heterogeneous by nature, these actors can be ei-
ther formal working groups formed by international experts
or representatives of organizations for a specific purpose or
mission (e.g. The Task Force on Global Action for Health
System Strengthening, called also the "Takemi Working
Group") or transnational networks that are formed from a
common interest (e.g. MDG Africa Steering Group, a group
of leader intergovernmental organizations). These actorsare developing rapidly and produce many reports that are
widely disseminated.
For each category, a list of major GHAs was compiled
through an iterative process (Table 1). According to our
knowledge of the context, we initially identified GHAs
according to their involvement – at the global level – in
health care financing and/or access to health care dis-
cussions. We then used the snowballing technique to
complete this list: we added to the list any new GHA
mentioned by previously identified GHAs and who met
the two criteria mentioned above. An expert in global
health also recommended the inclusion of other GHAs.
Data collection
Insofar as we are interested in a supranational debate in
the public arena, we chose to only analyze the official and
public position statements of GHAs. Because the World
Wide Web has become the major public relations medium
[29], we posited that GHAs willing to express a public
statement would use this channel of information to inform
the public and spread their message. As a consequence, we
opted to look for documents available on the Internet. We
also considered that documents that are not public or that
are under disclosure should not be part of our analysis be-
cause they are not accessible to the public. Furthermore,
because we focused on the Internet as the only source of
information, we ensured that the process of data collection
was as transparent, systematic and unbiased as possible.
The official websites of the listed GHAs were system-
atically and comprehensively consulted to find any
public documents. To be included in the study, a docu-
ment had to: 1) be in English or in French; 2) be pub-
lished between 2005 and 2011; 3) be published by a
GHA; 4) address the issue of development, poverty or
healthcare in LMICs; 5) be officially credited by the
GHA (documents marked “the views expressed in this
paper are solely those of the author” and similar were
excluded); 6) present a point of view, a strategy, a pos-
ition, a call, a plan of action, and not just an activity
report.
In order to get the most accurate vision of the possible po-
sitions of the GHAs, the "snowballing" technique was ap-
plied to selected documents. This technique allowed us to
take into account new actors that were gradually added to
the list of stakeholders. Key informants, whose research in-
terests focus on the issues of health system financing in
LMICs, access to health care for vulnerable populations and
equity, were also contacted. These persons directed us to
available documentation from conferences or international
meetings.
Data analysis
As a first step, we mapped the positions of the GHAs in the
debate on the abolition of user fees. We took the features of
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role of stakeholders in the political decision-making process.
This provides a focus on policy stakeholders, their interests
and their relationships [25], notably on health policy issues[30]. Such studies were recently conducted in LMICs about
universal health coverage in Tanzania [31] and about the in-
fluence of research on health systems in the policy-making
process [32].
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GHAs according to their position on the issue of user fees.
It classifies the GHAs into five groups: no stance, neutral
stance, negative stance, positive stance and nuanced stance.
When multiple documents were assigned to one GHA, the
most recent document in which a position was identified
was used to determine the GHA’ s position.
For each document, passages that were relevant to the
study were transcribed into a Microsoft Excel matrix for
easier data handling. The lead author applied the deci-
sion tree to all passages. A research assistant applied the
item 2 “Does the GHA take a stance on the issue of user
fees?” to all passages, except those already categorized
“No stance”. In order to limit observer bias, this step
was carried out blinded to knowledge of the authors of
the passages. An inter-observer agreement was calcu-
lated for item 2 using Cohen's kappa coefficient [33].1. Does the GHA bring 
up the issue of user fees / 
access to healthcare / 
free care?
yes
2. Does the GHA take a 
stance on the issue of user 
fee?
yes
3. Does the GHA state that it is
in favor of user fees OR
opposed to free care at the 
point of delivery?
no
4. Does the GHA state that it
is against user fees OR in 
favour of free care at the 
point of delivery?
no
5. Does the GHA state that it 
is both in favour of user fees 
and in favour of free care at 
the point of delivery?
Figure 1 Decision tree to classify GHAs according to their stance on tThe coefficient obtained was 88.9%. Disagreements were
resolved by consensus.
As a second step, the lead author conducted a thematic
analysis of the GHAs’ discourse to identify what argu-
ments were used to justify their position. Mapping the po-
sitions of the GHAs allowed us to inductively develop a
coding grid. This grid was applied to the passages com-
piled in the Microsoft Excel matrix, or to the entire docu-
ment when necessary. It was iteratively completed before
being finalized.
Results
Description of the GHAs and included documents
We identified 56 GHAs: 18 were intergovernmental orga-
nizations, 10 were government agencies, 8 were inter-
national non-governmental organizations and 20 were










he issue of user fees.
Table 2 Description of the documents included in the
study
IGOs GAs INGOs NW/
WGs
TOTAL
Total number of selected documents 38 34 27 41 140
Total number included in thematic
analysis
25 10 26 27 88
Nature of documents
Action plan / strategy 14 9 0 3 26
Call to action / lobby document 1 0 23 15 39
Position paper / statement of
principles
5 0 2 3 10
Report 5 1 1 6 13
Topic of documents
Health (general) 8 3 1 3 15
MDGs 3 0 0 7 10
User fees / access to healthcare 1 0 9 0 10
Poverty / development 2 5 2 7 16
Specific health issue 6 2 14 10 32
Other 5 0 0 0 5
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GHAs, with the exception of the African Development
Bank and International Health Partnership + for which we
could not find any relevant documents. Of these docu-
ments, 63 were excluded (Figure 2) because they did not
meet the inclusion criteria 5 and 6. The stakeholder analysis
was carried out using the 140 remaining documents. The
list of these documents is available in the Additional file 1.
Among them, 38 were published by intergovernmental or-
ganizations, 34 were published by government agencies, 27
by international non-governmental organizations, and 41
by working groups and transnational networks. The the-
matic analysis was performed on the 88 documents belong-
ing to the GHAs who have addressed the issue of access to
health care, user fees or exemption policies. Table 2 de-
scribes the different types of documents.
The majority of the documents in which the GHAs took
a stance in favor of free care or in favor of abolishing user
fees were published between 2008 and 2010 (Figure 3). Be-
tween 2005 and 2007, 19 documents (29%) were pub-
lished, six of these (32%) by INGOs, while 43 (66%) were
published between 2008 and 2010.Potentially relevant 
documents identified and 
screened for retrieval 
(n=203)
Documents included in 
stakeholders' mapping 
(n=140)







with reasons (no stance) 
(n=52)
Figure 2 Selection process of the documents.What are GHAs’ positions on user fees?
The GHAs that took a stance in the debate are for the
most part in favor of the abolition of user fees or in favor
of free care at the point of delivery. Indeed, 30 of them
(55%) fall into the category “Positive stance” (Table 3). No
GHA was in favor of user fees or against free care at point
of service. However, 43% of the GHAs remain silent about
the issue: either they do not address the issue (30%), or
they discuss it in a neutral manner (13%). A case in point
is UNAIDS, a United Nations partnership devoted to the
issue of HIV/AIDS, which describes user fees as a barrier
to access to care, without taking a stance:
“The costs of accessing services, including visit fees and
transport costs, can also be an important barrier,
especially among food-insecure people.” (p.38) [34]
Only one GHA, the World Bank, is both in favor of
user fees and in favor of free care at the point of delivery
(Table 3):
“[…] user fees have a role to play as copayment when
there is evidence of excess demand. […] Upon client-
country demand, the Bank stands ready to support
countries that want to remove user fees from public
facilities […]” (p.50) [35]
There are more INGOs that take a stance in favor of
free health care or against health user fees (75%) than
IGOs and GAs (respectively 41% and 30%). Similarly, GAs





























































































Figure 3 Distribution of GHAs by year of publication of documents. This figure shows the distribution of GHAs by year of publication of
documents in which they state that they are in favor of free care at the point of delivery or in favor of abolition of user fees. The size of each
year block is proportional to the number of documents published that year. When the number of documents published by a GHA is more than
one, the total number is indicated in brackets. The name of the GHA is highlighted when it is the first time it takes a positive stance from 2005.
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“Neutral stance” (70%), whereas two INGOs (25%) fall
into one of these two classes.
What characterizes the “positive stance” of GHAs?
In general, GHAs who take a stance in favor of free
care or in favor of the abolition of user fees specify the
populations or the type of services for which they are
in favor of such measures. Documents in which GHAs
take a stance often deal with mother and child health[35-37]. Some documents also deal with one or the other
of these populations [34,38,39] or with poor and vulner-
able populations [40-42].
With regard to the type of health services for which user
fees could be abolished according to the GHAs, the fol-
lowing are listed: basic health care [43-46], essential health
care [47-49], and primary health care [42,50,51]. GHAs
also discuss HIV/AIDS prevention, treatment and care
[52,53] and malaria [54]. The Global Call to Action against
Poverty - France specifically mentions long-term illness
Table 3 Distribution of GHAs according to their position in the health user fee debate
No stance
n = 16 (30%)
Neutral stance




n = 30 (55%)
Nuanced stance
n = 1 (2%)
IGOs UNDP Asian Development Bank African Union The World Bank
UNFPA European Parliament Council of the European Union
UN General Assembly Inter-American
Development Bank
ECHO
UNICEF OECD European Commission
WAHO International Labour Organization
World Health Assembly
WHO

















MDG Africa Steering Group
The Global Campaign for the Health
MDGs
UNAIDS
INGOs InterAction Action for Global Health
The Global Call to Action
Against Poverty
Action mondiale contre la pauvreté
Coordination Sud
Global Health Watch
Other Global Health Council The Global Coalition on
Women and AIDS
Countdown to 2015
P4H People' Health Movement
Taskforce on Innovative
International Financing for Health Systems
Task Force on Global
Action for Health System Strengthening
UN Millennium Project
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combination of populations and services, such as basic
health care for children under 5 [56,57].
Some GHAs sometimes formulate conditions in which
they support free health care: the World Bank [35,58],
ECHO [59], World Vision [36], Merlin [38], G8 [56,60]. For
example, ECHO stipulates that free health care must beguaranteed in emergency situations [59]. The World Bank
identifies three conditions:
“[…] (a) the lost revenue from user fees can be
replaced with resources that reach the facilities in a
timely and fiscally sustainable manner over the long-
term; (b) effective public financial management
Table 4 Distribution of GHAs according to the nature of
their arguments
Type of arguments IGOs GAs INGOs NWs/WGs TOTAL
1) Economics 6 2 6 6 20
2) Moral and ethics
Equity 6 2 4 2 14
Ethics 5 1 3 4 13
Human rights 2 1 4 3 10
3) Pragmatic
Health preoccupations 7 2 6 6 21
MDGs 4 2 4 11 21
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replacements will effectively reach the health facilities
that need them the most and in the context of the
appropriate incentive framework for the provision of
services to the poor; and (c) that resource replacements
will be used to pay for the delivery of effective quality
services for the poor, provided at the health facilities.”
(p.50) [35]
In addition, not all GHAs formulate their stance as dir-
ectly as Save the Children and some other INGOs who do
not hesitate to call for the abolition of user fees: “In order
to save the lives of children and enable the poorest families
to get the care they need, user fees must be abolished […]”
(p.3) [61]. For example, the Danish cooperation, while in
favor of free care at the point of care, emphasizes the need
to promote alternative financing mechanisms:
“An important strategy towards improved coverage
and universal access to health services is to reduce
out-of-pocket spending and ensure social protection
against catastrophic health expenditures. A mix of
financing mechanisms is needed in most countries in
order to achieve this aim. […] abolition of user fees is
a strategy that cannot guarantee quality of service and
be a stand-alone strategy.” (p.15) [62]
The documents from intergovernmental organiza-
tions often mentioned the idea that user fees should
be avoided, while suggesting other financing mecha-
nisms, rather than removing them outright. This is
particularly the case of the African Union [63], Coun-
cil of the European Union [64], the World Health As-
sembly [65] and WHO [50,66].
Detailed characteristics on GHAs’ suggested measures,
as well as target populations and services, are available
in the Additional file 2.
What arguments do GHAs use to justify their stance?
International non-governmental organizations are more
likely to condemn user fees than other GHAs who might
have previously promoted and supported their imple-
mentation. The discourse of intergovernmental organi-
zations more often calls on a set of universal values such
as fairness, justice, or the right to health (see below).
Their discourse is not as committed as that of INGOs
and they rarely highlight the disadvantages of user fees,
such as the African Union:
“In exploring additional sources of revenue countries
should work towards a solidarity model within a
framework of equity, seeking to implement pre-
payment systems to avoid user fees at the time that
care needs to be sought.” p.11 [67]Notable exceptions among intergovernmental organi-
zations are WHO and ECHO, who are true campaigners
against user fees.
Regarding the nature of the arguments, we identified three
main types of arguments (Table 4): economic arguments,
moral and ethical arguments, and pragmatic arguments.
Economic arguments are built around two rationales. The
first one concerns the catastrophic health expenditures that
households incur specifically as a result of user fees. These
catastrophic expenditures would lead to the further impov-
erishment of the poorest households: “Where user fees exist,
those who struggle to pay can be pushed further into poverty
or debt” (p.1) [61]. Some GHAs also present their views in
the context of the fight against poverty and the promotion
of growth, as indicated by the titles of documents, including
one from the Council of the European Union: “The EU as a
global partner for pro-poor and pro-growth development”
[52]. The second rationale relates directly to the effective-
ness of the health system. Indeed, user fees would not be
“the best return on investment” (p.25) [68] and their aboli-
tion would improve the cost-effectiveness of health services
by promoting the use of services (p.69) [69].
With regard to moral and ethical arguments, equity is
the reason most frequently cited by GHAs to justify their
stance in the debate on user fees, and this view is relatively
homogeneous. On one hand, user fees appear to be the
most inequitable financing mechanism of health systems:
“Direct payments are the least equitable form of health
funding.” (p.42) [66]. On the other hand, they are consid-
ered to have failed to ensure equitable access to health
[44].
User fees are also condemned because they accentuate
gender inequalities as women often need to ask for money
from their husbands before seeking care [38,68]. Other
ethical arguments are used by GHAs. They declare that
user fees are a source of exclusion and discrimination
[57,70,71], that they are unfair [61,63] or “intolerable” [59],
and that they pose a threat to life itself [72,73].
Some GHAs, especially international non-governmental
organizations, take a principled stand in favor of the right to
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mitments to child survival are legal obligations enshrined in
a series of international human rights instruments” (p.1)
[74]. Lastly, one NW/WG – the People’s Health Movement
– considers that “health services must be democratic” (p.11)
and should therefore be free of charge [75].
In the case of pragmatic arguments, health concerns
of populations are the most frequently cited. Indeed, for
GHAs, user fees are a barrier that prevents people, es-
pecially the poorest, from accessing health care [66,73].
This barrier should be removed in order to improve ac-
cess to health care and use of health services [37,45,65],
as well as early diagnostics [51], to eliminate certain dis-
eases [45,54,76], to improve quality and coverage of health
services [38,51], and ultimately to save lives [36,43,77].
The second argument used by GHAs concerns the health
Millennium Development Goals. According to the vast
majority of GHAs, removing user fees would contribute to
achieve the health Millennium Development Goals:
“In the absence of more pro-poor funding policies being
put in place in these countries – including providing
care free at the point of use – the current lack of
progress towards MDG 4 looks set to continue.” (p.36)
[78]
These arguments appeal to several concepts and ideas
like poverty, development, equity, or the right to health,
for which GHAs do not specify any definition in the docu-
ments included in the study.
To conclude, we note that several GHAs strengthen
their argument by using scientific literature (n = 14), gray
literature (n = 20), or their own research results or experi-
ence (n = 7).
Discussion
Key messages
Our study shows that promoting user fees as a way of fi-
nancing health systems of LMICs is no longer the trend.
There is indeed a consensus among GHAs who take a
stand, at least from a rhetorical point of view, in favor of
avoiding user fees at the point of delivery. User fees are
deemed not only as the most inequitable means of health
system financing, but also as a major barrier to access to
care. However, the consensus is less obvious on the action.
Most GHAs suggest abolishing user fees or establishing free
access to health services. Several others, including intergov-
ernmental organizations, avoid mentioning free healthcare;
rather, they emphasize the need to find alternative mecha-
nisms of financial protection, such as social protection
[64,79] or pre-payment mechanisms [63,65]. As shown in
the Additional file 2, beneficiaries of these measures are
often identified as the most vulnerable and the poorest and
coincide with the target beneficiaries of the healthMillennium Development Goals (mothers, children under
5, people living with HIV/AIDS). This is consistent with the
statements made by some GHAs that user fees hinder the
achievement of the Millennium Development Goals by
slowing access to health care.
Our study also shows that international non-governmental
organizations are more likely to take a stand than other
GHAs. Most [80-83] have an advocacy mission, which
leads them to take sides on diverse development or hu-
manitarian issues, such as access to care. They are also
direct witnesses of the problem of access to care for vul-
nerable populations. In contrast, few government agen-
cies take a stand, probably because of their position in
the global agora. Indeed, government agencies are re-
sponsible for implementing the foreign policy of their
country, whose first aim is to defend its national inter-
ests on the international scene [84,85]. Each undertak-
ing is part of a complex diplomatic logic [85], especially
as some are among the largest donors in the field of
health.
History of changes
While some international non-governmental organizations
have been defending the principle of free care for a long
time, this is not the case of government agencies and inter-
governmental organizations that have sometimes contrib-
uted - directly or indirectly - to the implementation of user
fees. Indeed, UNICEF and WHO influenced the Bamako
Initiative, which promoted user fees in LMICs. At that time,
the World Bank was becoming influential in the health sec-
tor, transforming power relations on the international health
scene [86-88]. Although it was not involved in the develop-
ment of the Bamako Initiative, it pursued structural adjust-
ment programs in developing countries since the early
1980s that aimed to reduce public spending in the social
sectors. These programs contributed to the expansion of the
Bamako Initiative. The diversification and expansion of the
World Bank to the health sector influenced the nature of
health financing reforms, leading to the “fabrication of a
consensus”, as put by Serre and Pierru [88].
This movement was part of a broader discussion about
health system financing in Western countries and in LMICs,
which started in the early 1990s. In this way, “[…] the propa-
gation of HCF (health care financing) has been […] shaped
by the building of a consensus across different institutions
and national settings, defining the 'problem' of HCF and po-
tential solutions” [87]. Through its financial strength and
technical expertise, the World Bank became the leader on
the global health scene [89], defining new norms and rules
for international cooperation organizations, academic insti-
tutions and policy makers of LMICs who were dependent
on international aid [86]. A paradigm was born and contrib-
uted to influence the vast majority of health care financing
reforms in LMICs, particularly on the African continent.
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ized by a change in the stance of major GHAs, including
intergovernmental organizations. Indeed, between the
stance of the World Bank in 1987 and its stance twenty
years later [35], the dominant principle of user-pays has
fizzled out. The recent speech by its president Jim Yong
Kim at the World Health Assembly [90] in May 2013
gives effect to this change. He claimed there: “Anyone
who has provided health care to poor people knows that
even tiny out-of-pocket charges can drastically reduce
their use of needed services. This is both unjust and
unnecessary.”Incremental reform or fundamental change?
Is this change incremental or fundamental? As op-
posed to incremental change, fundamental or paradig-
matic change is “a fundamentally new direction […],
also understood as signifying the emergence of a new
paradigm or way of thinking about a policy issue.” [91].
If our study shows the existence of a consensus, it also
shows that some intergovernmental organizations and
working groups and transnational networks have a nu-
anced stance and abstain, in particular, from promot-
ing the abolition of user fees. They have a moderate
discourse in which one perceives a tension between the
desire to support the abolition of direct payments, for
the sake of fairness and social justice, and the need to
provide solutions to ensure the sustainability of health
care financing. The same tension exists in the discourse
of health staff, particularly in Mali, who admit that user
fees are a barrier to access to health care for the poor,
while remaining cautious about possible alternatives [92].
Therefore, the consensus may be more about the need to
find alternative ways to finance equitable health systems,
such as universal health coverage.
In addition, we may legitimately ask whether certain
intergovernmental organizations’ statements are not empty
statements of principle. Indeed, speech façades, that use the
vocabulary promoted by civil society in particular, are no
stranger to international health policy [93]. For example,
the goal of fairness that is shared by all GHAs and that
helps justify their stance is never defined. The more system-
atic presence of this objective in the discourse of GHAs is
certainly a step towards the establishment of common
values within the international community [94]. Yet, the
risk that it becomes a slogan for some GHAs is present.Evidence and networks: the drivers of change
The change of GHAs’ stance can be explained by the co-
existence of several factors. We believe that the produc-
tion and dissemination of scientific evidence on user
fees and the influence of some networks of actors in glo-
bal health have contributed to this change.Since the 1990s, the evidence-based approach has gained
interest, particularly in the area of political decision-making
[95]. This approach aims to encourage policy-makers to take
scientific evidence into consideration when developing new
policies. International organizations have undertaken to con-
tribute to the production of knowledge, either through their
own publications [88,95], or through the financing of re-
search in the academic world [87]. This evidence could
allow some intergovernmental organizations to justify par-
ticular discourses and promote specific policies, from a stra-
tegic and argumentative perspective [88].
Given the considerable challenge of health care finan-
cing reforms, and in order to inform policy makers and
the public about the effects of these reforms, many re-
searchers have focused on the impact of user fees on
utilization of health services by populations [15]. For their
part, INGOs, especially Save the Children, have capitalized
on their field experience to produce information on the ef-
fects of user fees on access to care for vulnerable popula-
tions [48,96]. Despite the methodological limitations of
these studies, the results mostly demonstrated a negative
impact of user fees on access to health care for the poor
[11]. This abundance of scientific evidence and field ex-
perience may have contributed to change the position of
GHAs. It also strengthened the committed discourse of
INGOs, as shown by the use of scientific literature in their
documents. If evidence could not be the single factor
changing the position of intergovernmental organizations,
it certainly contributed to the already strong debate be-
tween supporters and critics of user fees, while casting
doubt on these cost recovery policies in the minds of
LMICs policy makers.
Knowledge can contribute to political change, but only as
the instrument of change that actors must use. These ac-
tors, whether they are individual or collective, have beliefs
and values. They have goals they seek to achieve through
the mobilization of resources and they are constrained by
rules and institutions [97]. Advocacy networks offer an in-
teresting perspective for understanding the involvement of
different actors in policy changes over long periods [98].
These networks consist of “persons holding a variety of po-
sitions (elected officials, interest group leaders, researchers)
who share a particular belief system – i.e., a set of basic
values, causal reasoning, and perceptions of problems – and
who show a significant degree of coordinated activity over
time”. In this perspective, ideas have an important role in
the process of change and elaboration of public policy at
the national level. Two types of networks seem to have
played a role in the political change of health care financing
in LMICs: global policy networks, particularly transnational
political elite [87], and transnational advocacy networks
[99].
Lee et Goodman [87] trace the path of health care finan-
cing reforms and show the role of global policy networks
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through a range of research and training initiatives, project
funding, the career movement of individuals, and other
forms of collaborative work across higher- and lower-income
countries, health economics and public health, and public
and private sectors." The authors highlight the "transatlan-
tic divide” between American schools of thought, which
are in favor of user fees, and European schools, which are
rather unfavorable to user fees. The scope of this study
ends in the 2000s and offers a historical perspective that is
necessary to understand how the terms of the debate on
user fees in LMICs evolved. For further analysis, we could
focus on elements recognized as having fostered the emer-
gence of a consensus, including how European schools of
thought have gained legitimacy, to the point of participat-
ing in reversing dominant positions.
Transnational advocacy networks [99] differ from advo-
cacy networks not only by their transnational character,
but also by their activism. A transnational advocacy net-
work “includes those relevant actors working internation-
ally on an issue, who are bound together by shared values,
a common discourse, and dense exchanges of information
and services.” Among these networks, INGOs play a cen-
tral role, as they are able to initiate actions and put pres-
sure on key international stakeholders. Indeed, INGOs
“participate in the agenda setting of international issues, in
the decision-making process and in the implementation of
international action programs” [100]. Several INGOs have
published a large number of reports showing the negative
effects of user fees on access to care for the poor, while put-
ting pressure on their government and / or intergovern-
mental organizations to make them take a clear position in
favor of free care at the point of delivery. Transnational ad-
vocacy networks have several levers to influence policy
decision-making [99]: “information politics” which is the
capacity to quickly mobilize politically relevant information;
“symbolic politics” which is the ability to use symbols or
striking stories to give meaning to action; “leverage politics”
which is the ability to solicit more powerful stakeholders to
influence a situation; “accountability politics” which is the
ability to compel actors to comply with their declaration of
intent. We think that the study of these tactics would allow
a better understanding of the influence that these actors
have had in changing the stance of intergovernmental orga-
nizations and government agencies with respect to user fees
in LMICs.
Beyond these two drivers of change, our study suggests a
third driver: the LMICs themselves. We note that the publi-
cation of documents in which GHAs take a stand in favor
of free care or the abolition of user fees increases between
2008 and 2010. It is during this period that influential
stakeholders such as the WHO, the European Commission,
the G8 and several working groups and transnational
networks take a stand in the debate. However, thesedocuments follow the decision of several LMICs to imple-
ment user fee exemption policies. Indeed, Ghana and
Burkina Faso opted for exemption policies for maternal
health in 2003, followed in 2005 by Niger, Mali and Senegal
[19]. This suggests that most GHAs may have felt they had
to take a stand with regard to the policies initiated by
LMICs. However, the multiplicity of exemption measures
since 2009, particularly in West Africa, suggests that the
stance of GHAs has in turn prompted other LMICs such
as Côte d'Ivoire, Togo and Sierra Leone to implement ex-
emption policies.
From words to deeds
Whatever the nature of the change that is taking place on
the international health scene, the stance of GHAs alone
is ineffective in improving the health of populations. Even
if “change may be symbolic before being concrete due to the
performative dimension of political discourse” [100], it
must be transformed into action to last. The first to take
action were international non-governmental organiza-
tions, including MSF and MDM. Their documents show
their experiences in implementing free health care at the
local level. These experiences provided them with argu-
ments for their lobby campaigns. More recently, intergov-
ernmental organizations have pressured governments of
LMICs to introduce user fee exemption measures. As an
example, in Burkina Faso, the World Bank has supported
the implementation of the subsidy for emergency obstetric
and neonatal care [101]. In Niger, the Bank has subordi-
nated loans to the introduction of free health care for chil-
dren under 5 [102]. However, the Bank’s conditions were
not followed by technical or financial support. In Niger, it
has not provided the necessary financial support to ensure
the smooth functioning of the exemption measures it ad-
vocated. This has forced the country to turn to other do-
nors, such as the French cooperation [102] which allowed
a part of its aid to be used to fund free care for children
under 5. The limits of their actions could explain why
intergovernmental organizations tend not to mention free
care or exemption policies as possible solutions, and
merely highlight the inequitable nature of user fees.
These examples illustrate the difficulties faced by LMICs
to implementing user fee exemption policies, without the
support of donors. Indeed, although many exemption pol-
icies were implemented in several sub-Saharan African
countries, their outcomes in terms of service utilization
were marred by problems of implementation. A lack of
preparation, both operational and financial, has been
highlighted in many studies [18,103]. A major repercus-
sion was the return of illegal user fees [104-106], which
may counteract the expected policy effects. Furthermore,
exemption policies’ sustainability is far from assured [107],
and out-of-pocket payments remain an issue for those
who do not benefit from these policies or have to pay for
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have generally shown their potential to improve health
services utilization [108-110], user fee exemption policies
are rarely promoted as a way to ensure equitable access to
healthcare. However they are increasingly seen as a step
towards universal health coverage [20,107,111]. In this
context, the debate now seems to be more about the most
effective and equitable mechanisms to achieve universal
health coverage in LMICs.
Limits
Although we conducted the study so as to limit bias, in-
cluding interpretation bias, our work has some limitations
that are inherent to the research design. First, because we
used only secondary data, we limited our analysis to the
official and public discourse of major stakeholders. How-
ever, as shown in the case of Niger, where France sup-
ported the user fee exemption policy, the absence of
documents addressing the issue of user fees by some
GHAs does not mean that there are no positions taken on
“the ground”. Similarly, the financial or technical support
by a GHA for a national user fee exemption policy or a
local free care program does not necessarily mean that it
takes a stand against health user fees or for universal free
care. Such actions may be motivated by contextual consid-
erations that are political, social or health-related.
In addition, it is possible that certain documents were not
found, a major challenge being to ensure the completeness
of the data collection strategy. We recall in this respect that
the documents marked “the views expressed in this paper
are solely those of the author” and similar were excluded. It
is also possible that other GHAs not included in our initial
sample expressed opinions on the issue of user fees. How-
ever, we could not trace their presence in the debate. Indeed,
the multiplicity of stakeholders makes it difficult to ensure
their full representation. Moreover, the data collection strat-
egy ended in mid-2011; other documents may have been
published since and state, specify or modify the stance of
some GHAs. Ensuring that findings are up-to-date can be
challenging when dealing with global policy issues that are
very contemporary and are under close scrutiny.
Finally, the objective of this study was to identify and
analyze the public position statements of GHAs in the de-
bate on health user fees. It would have been particularly
interesting to understand the evolution of the change in
the stances of GHAs in this debate and analyze how it re-
lates to the international debate on healthcare financing.
However this is beyond the scope of our study.
Conclusion
Our study is one of the few to analyze the stance of GHAs
on a global health policy issue based on the analysis of pub-
lic documents. It shows that there is a consensus on the
need to make health care free at the point of delivery inLMICs to ensure equitable access for all. The consensus
seems to follow, not precede, the establishment of user fee
exemption policies in some LMICs. While universal health
coverage becomes the new objective in global health policy,
free care at the point of delivery is far from being a reality
for many citizens in LMICs. This is why GHAs, and espe-
cially intergovernmental organizations, should not settle for
a speech front and must translate their words into action.
Intergovernmental organizations and government agencies
who have the necessary means must ensure both technical
and financial support to the governments of LMICs com-
mitted to implement user fee exemption policies. As for the
scientific community, we should continue our work to im-
prove GHAs’ understanding of challenges, successes and
obstacles faced by governments when implementing such
reforms. We also need to better understand the historical
evolution of the debate on user fees, as a way to understand
global governance and how it influences public health pol-
icies in LMICs.
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